| Malignant Skin Neoplasm altered in cohorts of …ALTERED_INderived200 of 598show all (up to 200) |
|---|
| ← altered in cohorts of | MUC12 24 / 25 cases (96 %) · ssm · cscc_ranson_2022 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PLEC 22 / 25 cases (88 %) · ssm · cscc_ranson_2022 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | WDFY4 22 / 25 cases (88 %) · ssm · cscc_ranson_2022 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HMCN2 21 / 25 cases (84 %) · ssm · cscc_ranson_2022 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TERT 575 / 696 cases (83 %) · ssm · mel_mskimpact_2020 | — | — | Cutaneous Melanoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TTN 388 / 470 cases (83 %) · ssm · TCGA-SKCM · largest of 13 cohorts | — | — | Cutaneous Melanoma | 13 | Observed | gdc | graph → |
| ← altered in cohorts of | MUC16 377 / 470 cases (80 %) · ssm · TCGA-SKCM · largest of 13 cohorts | — | — | Cutaneous Melanoma | 13 | Observed | gdc | graph → |
| ← altered in cohorts of | AKAP6 20 / 25 cases (80 %) · ssm · cscc_ranson_2022 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CDH23 20 / 25 cases (80 %) · ssm · cscc_ranson_2022 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC3A 20 / 25 cases (80 %) · ssm · cscc_ranson_2022 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC5AC 20 / 25 cases (80 %) · ssm · cscc_ranson_2022 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PTPRQ 20 / 25 cases (80 %) · ssm · cscc_ranson_2022 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SHANK1 20 / 25 cases (80 %) · ssm · cscc_ranson_2022 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TNRC18 20 / 25 cases (80 %) · ssm · cscc_ranson_2022 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ANK3 375 / 470 cases (80 %) · ssm · TCGA-SKCM · largest of 11 cohorts | — | — | Cutaneous Melanoma | 11 | Observed | gdc | graph → |
| ← altered in cohorts of | CDKN2B 356 / 470 cases (76 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DMBT1 352 / 470 cases (75 %) · ssm · TCGA-SKCM · largest of 6 cohorts | — | — | Cutaneous Melanoma | 6 | Observed | gdc | graph → |
| ← altered in cohorts of | FREM1 352 / 470 cases (75 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MTAP 351 / 470 cases (75 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DNAH5 350 / 470 cases (74 %) · ssm · TCGA-SKCM · largest of 14 cohorts | — | — | Cutaneous Melanoma | 14 | Observed | gdc | graph → |
| ← altered in cohorts of | DMRTA1 346 / 470 cases (74 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PCLO 342 / 470 cases (73 %) · ssm · TCGA-SKCM · largest of 12 cohorts | — | — | Cutaneous Melanoma | 12 | Observed | gdc | graph → |
| ← altered in cohorts of | TAF1L 342 / 470 cases (73 %) · ssm · TCGA-SKCM · largest of 4 cohorts | — | — | Cutaneous Melanoma | 4 | Observed | gdc | graph → |
| ← altered in cohorts of | ADAMTSL1 341 / 470 cases (73 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNA16 341 / 470 cases (73 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNE 341 / 470 cases (73 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SYNE1 341 / 470 cases (73 %) · ssm · TCGA-SKCM · largest of 11 cohorts | — | — | Cutaneous Melanoma | 11 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNA7 340 / 470 cases (72 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNA14 339 / 470 cases (72 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNA4 339 / 470 cases (72 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MGAM 339 / 470 cases (72 %) · ssm · TCGA-SKCM · largest of 9 cohorts | — | — | Cutaneous Melanoma | 9 | Observed | gdc | graph → |
| ← altered in cohorts of | PCDH15 339 / 470 cases (72 %) · ssm · TCGA-SKCM · largest of 13 cohorts | — | — | Cutaneous Melanoma | 13 | Observed | gdc | graph → |
| ← altered in cohorts of | BNC2 338 / 470 cases (72 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ELAVL2 338 / 470 cases (72 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FOCAD 338 / 470 cases (72 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNA21 338 / 470 cases (72 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNA6 338 / 470 cases (72 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SH3GL2 337 / 470 cases (72 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNA10 336 / 470 cases (71 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNA13 336 / 470 cases (71 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNB1 336 / 470 cases (71 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNW1 336 / 470 cases (71 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CER1 335 / 470 cases (71 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNA1 335 / 470 cases (71 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNA17 335 / 470 cases (71 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNA2 335 / 470 cases (71 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNA5 335 / 470 cases (71 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KLHL9 335 / 470 cases (71 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MPDZ 335 / 470 cases (71 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SAXO1 335 / 470 cases (71 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CNTLN 334 / 470 cases (71 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HACD4 334 / 470 cases (71 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFNA8 334 / 470 cases (71 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TYRP1 334 / 470 cases (71 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TACC2 333 / 470 cases (71 %) · ssm · TCGA-SKCM · largest of 6 cohorts | — | — | Cutaneous Melanoma | 6 | Observed | gdc | graph → |
| ← altered in cohorts of | CCDC171 331 / 470 cases (70 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DOCK8 330 / 470 cases (70 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MLLT3 330 / 470 cases (70 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC24A2 330 / 470 cases (70 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TEK 330 / 470 cases (70 %) · ssm · TCGA-SKCM · largest of 2 cohorts | — | — | Cutaneous Melanoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | TTC39B 330 / 470 cases (70 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HAUS6 329 / 470 cases (70 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NFIB 329 / 470 cases (70 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PSIP1 329 / 470 cases (70 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZDHHC21 329 / 470 cases (70 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ACER2 328 / 470 cases (70 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DMRT3 328 / 470 cases (70 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LURAP1L 328 / 470 cases (70 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PLIN2 328 / 470 cases (70 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RPS6 328 / 470 cases (70 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SMARCA2 328 / 470 cases (70 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SNAPC3 328 / 470 cases (70 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DENND4C 327 / 470 cases (70 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GLIS3 327 / 470 cases (70 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | INSL6 327 / 470 cases (70 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RRAGA 327 / 470 cases (70 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DMRT1 325 / 470 cases (69 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IZUMO3 325 / 470 cases (69 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | JAK2 325 / 470 cases (69 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GLDC 324 / 470 cases (69 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KDM4C 324 / 470 cases (69 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RCL1 324 / 470 cases (69 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | INSL4 323 / 470 cases (69 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LINGO2 323 / 470 cases (69 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CD274 322 / 470 cases (69 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KIAA2026 322 / 470 cases (69 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SORCS3 322 / 470 cases (69 %) · ssm · TCGA-SKCM · largest of 4 cohorts | — | — | Cutaneous Melanoma | 4 | Observed | gdc | graph → |
| ← altered in cohorts of | TPD52L3 322 / 470 cases (69 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DMRT2 321 / 470 cases (68 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ERMP1 321 / 470 cases (68 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IL33 321 / 470 cases (68 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KCNV2 321 / 470 cases (68 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PLGRKT 321 / 470 cases (68 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RLN1 321 / 470 cases (68 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DMAC1 320 / 470 cases (68 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DNAH8 320 / 470 cases (68 %) · ssm · TCGA-SKCM · largest of 13 cohorts | — | — | Cutaneous Melanoma | 13 | Observed | gdc | graph → |
| ← altered in cohorts of | KANK1 320 / 470 cases (68 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PDCD1LG2 320 / 470 cases (68 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RANBP6 320 / 470 cases (68 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RFX3 320 / 470 cases (68 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RIC1 320 / 470 cases (68 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RLN2 320 / 470 cases (68 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC1A1 320 / 470 cases (68 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TUSC1 320 / 470 cases (68 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | VLDLR 320 / 470 cases (68 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CYP2C19 319 / 470 cases (68 %) · ssm · TCGA-SKCM · largest of 2 cohorts | — | — | Cutaneous Melanoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | IFT74 319 / 470 cases (68 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LRRC19 319 / 470 cases (68 %) · ssm · TCGA-SKCM | — | — | Cutaneous Melanoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | COL6A5 24 / 39 cases (62 %) · ssm · cscc_hgsc_bcm_2014 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH6 23 / 39 cases (59 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZNF469 23 / 39 cases (59 %) · ssm · cscc_hgsc_bcm_2014 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DGKB 22 / 39 cases (56 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | EYS 21 / 39 cases (54 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FPGT-TNNI3K 21 / 39 cases (54 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PCDHAC2 184 / 346 cases (53 %) · ssm · skcm_tcga_pub_2015 | — | — | Cutaneous Melanoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | THSD7A 20 / 39 cases (51 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | UNC80 20 / 39 cases (51 %) · ssm · cscc_hgsc_bcm_2014 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PCDHGC5 164 / 346 cases (47 %) · ssm · skcm_tcga_pub_2015 | — | — | Cutaneous Melanoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | BRAF 301 / 696 cases (43 %) · ssm · mel_mskimpact_2020 · largest of 12 cohorts | — | — | Cutaneous Melanoma | 12 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DCHS2 54 / 126 cases (43 %) · ssm · bcc_unige_2016 · largest of 4 cohorts | — | — | Skin Basal Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL6A6 53 / 126 cases (42 %) · ssm · bcc_unige_2016 · largest of 4 cohorts | — | — | Skin Basal Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | AHNAK 119 / 293 cases (41 %) · ssm · bcc_unige_2016 · largest of 3 cohorts | — | — | Skin Basal Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL1A2 51 / 126 cases (40 %) · ssm · bcc_unige_2016 · largest of 4 cohorts | — | — | Skin Basal Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RIMS1 51 / 126 cases (40 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TEX15 51 / 126 cases (40 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZNF804B 51 / 126 cases (40 %) · ssm · bcc_unige_2016 · largest of 3 cohorts | — | — | Skin Basal Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CRIPAK 31 / 78 cases (40 %) · ssm · skcm_broad_brafresist_2012 | — | — | Cutaneous Melanoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PRG4 31 / 78 cases (40 %) · ssm · skcm_broad_brafresist_2012 | — | — | Cutaneous Melanoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FBN1 50 / 126 cases (40 %) · ssm · bcc_unige_2016 · largest of 2 cohorts | — | — | Skin Basal Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TMEM132D 50 / 126 cases (40 %) · ssm · bcc_unige_2016 · largest of 2 cohorts | — | — | Skin Basal Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LRP1B 182 / 469 cases (39 %) · ssm · skcm_tcga_gdc · largest of 13 cohorts | — | — | Cutaneous Melanoma | 13 | Observed | cbioportal | graph → |
| ← altered in cohorts of | GPR158 48 / 126 cases (38 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SCN7A 48 / 126 cases (38 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TRIOBP 48 / 126 cases (38 %) · ssm · bcc_unige_2016 · largest of 2 cohorts | — | — | Skin Basal Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DMD 47 / 126 cases (37 %) · ssm · bcc_unige_2016 · largest of 2 cohorts | — | — | Skin Basal Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PCDHA3 47 / 126 cases (37 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PLCL1 47 / 126 cases (37 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TCHH 29 / 78 cases (37 %) · ssm · skcm_broad_brafresist_2012 | — | — | Cutaneous Melanoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PRB2 46 / 126 cases (37 %) · ssm · bcc_unige_2016 · largest of 2 cohorts | — | — | Skin Basal Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PTPRT 254 / 696 cases (36 %) · ssm · mel_mskimpact_2020 · largest of 7 cohorts | — | — | Cutaneous Melanoma | 7 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CHD7 45 / 126 cases (36 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL24A1 45 / 126 cases (36 %) · ssm · bcc_unige_2016 · largest of 2 cohorts | — | — | Skin Basal Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FSTL5 45 / 126 cases (36 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ITPR1 45 / 126 cases (36 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LRRC7 45 / 126 cases (36 %) · ssm · bcc_unige_2016 · largest of 2 cohorts | — | — | Skin Basal Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ADGRV1 166 / 469 cases (35 %) · ssm · skcm_tcga_gdc · largest of 12 cohorts | — | — | Cutaneous Melanoma | 12 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL19A1 44 / 126 cases (35 %) · ssm · bcc_unige_2016 · largest of 2 cohorts | — | — | Skin Basal Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MYO16 44 / 126 cases (35 %) · ssm · bcc_unige_2016 · largest of 3 cohorts | — | — | Skin Basal Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NAV3 44 / 126 cases (35 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NLRP13 44 / 126 cases (35 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CACNA1A 43 / 126 cases (34 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CFAP47 43 / 126 cases (34 %) · ssm · bcc_unige_2016 · largest of 2 cohorts | — | — | Skin Basal Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ROBO2 99 / 293 cases (34 %) · ssm · bcc_unige_2016 · largest of 2 cohorts | — | — | Skin Basal Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FSIP2 28 / 83 cases (34 %) · ssm · cscc_ucsf_2021 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | GRM8 98 / 293 cases (33 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CSMD1 156 / 469 cases (33 %) · ssm · skcm_tcga_gdc · largest of 11 cohorts | — | — | Cutaneous Melanoma | 11 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH7 156 / 469 cases (33 %) · ssm · skcm_tcga_gdc · largest of 11 cohorts | — | — | Cutaneous Melanoma | 11 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MDN1 27 / 83 cases (33 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PKHD1L1 151 / 469 cases (32 %) · ssm · skcm_tcga_gdc · largest of 11 cohorts | — | — | Cutaneous Melanoma | 11 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RP1 151 / 469 cases (32 %) · ssm · skcm_tcga_gdc · largest of 12 cohorts | — | — | Cutaneous Melanoma | 12 | Observed | cbioportal | graph → |
| ← altered in cohorts of | XIRP2 151 / 469 cases (32 %) · ssm · skcm_tcga_gdc · largest of 9 cohorts | — | — | Cutaneous Melanoma | 9 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HYDIN 149 / 469 cases (32 %) · ssm · skcm_tcga_gdc · largest of 10 cohorts | — | — | Cutaneous Melanoma | 10 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FAT4 148 / 469 cases (32 %) · ssm · skcm_tcga_gdc · largest of 12 cohorts | — | — | Cutaneous Melanoma | 12 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ALMS1 26 / 83 cases (31 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | GRIN2A 217 / 696 cases (31 %) · ssm · mel_mskimpact_2020 · largest of 8 cohorts | — | — | Cutaneous Melanoma | 8 | Observed | cbioportal | graph → |
| ← altered in cohorts of | APOB 145 / 469 cases (31 %) · ssm · skcm_tcga_gdc · largest of 12 cohorts | — | — | Cutaneous Melanoma | 12 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DSCAM 145 / 469 cases (31 %) · ssm · skcm_tcga_gdc · largest of 11 cohorts | — | — | Cutaneous Melanoma | 11 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FLG 143 / 469 cases (30 %) · ssm · skcm_tcga_gdc · largest of 11 cohorts | — | — | Cutaneous Melanoma | 11 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CSMD3 141 / 469 cases (30 %) · ssm · skcm_tcga_gdc · largest of 11 cohorts | — | — | Cutaneous Melanoma | 11 | Observed | cbioportal | graph → |
| ← altered in cohorts of | USH2A 141 / 469 cases (30 %) · ssm · skcm_tcga_gdc · largest of 13 cohorts | — | — | Cutaneous Melanoma | 13 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MYCN 88 / 293 cases (30 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NRAS 207 / 696 cases (30 %) · ssm · mel_mskimpact_2020 · largest of 7 cohorts | — | — | Cutaneous Melanoma | 7 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC17 139 / 469 cases (30 %) · ssm · skcm_tcga_gdc · largest of 11 cohorts | — | — | Cutaneous Melanoma | 11 | Observed | cbioportal | graph → |
| ← altered in cohorts of | THSD7B 139 / 469 cases (30 %) · ssm · skcm_tcga_gdc · largest of 7 cohorts | — | — | Cutaneous Melanoma | 7 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CSMD2 138 / 469 cases (29 %) · ssm · skcm_tcga_gdc · largest of 12 cohorts | — | — | Cutaneous Melanoma | 12 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FAT3 138 / 469 cases (29 %) · ssm · skcm_tcga_gdc · largest of 8 cohorts | — | — | Cutaneous Melanoma | 8 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH9 137 / 469 cases (29 %) · ssm · skcm_tcga_gdc · largest of 9 cohorts | — | — | Cutaneous Melanoma | 9 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DYNC1H1 24 / 83 cases (29 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PTPRD 199 / 696 cases (29 %) · ssm · mel_mskimpact_2020 · largest of 10 cohorts | — | — | Cutaneous Melanoma | 10 | Observed | cbioportal | graph → |
| ← altered in cohorts of | EP400 82 / 293 cases (28 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LRFN5 82 / 293 cases (28 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MYH9 82 / 293 cases (28 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NF1 194 / 696 cases (28 %) · ssm · mel_mskimpact_2020 · largest of 3 cohorts | — | — | Cutaneous Melanoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ROS1 194 / 696 cases (28 %) · ssm · mel_mskimpact_2020 · largest of 8 cohorts | — | — | Cutaneous Melanoma | 8 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH3 130 / 469 cases (28 %) · ssm · skcm_tcga_gdc · largest of 11 cohorts | — | — | Cutaneous Melanoma | 11 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MXRA5 129 / 469 cases (28 %) · ssm · skcm_tcga_gdc · largest of 7 cohorts | — | — | Cutaneous Melanoma | 7 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SPHKAP 128 / 469 cases (27 %) · ssm · skcm_tcga_gdc · largest of 9 cohorts | — | — | Cutaneous Melanoma | 9 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PAK5 189 / 696 cases (27 %) · ssm · mel_mskimpact_2020 · largest of 4 cohorts | — | — | Cutaneous Melanoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RNF213 79 / 293 cases (27 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NBPF10 21 / 78 cases (27 %) · ssm · skcm_broad_brafresist_2012 | — | — | Cutaneous Melanoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DMXL2 22 / 83 cases (27 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DOCK2 22 / 83 cases (27 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HERC2 22 / 83 cases (27 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LAMA1 22 / 83 cases (27 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SYNE2 22 / 83 cases (27 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TP53 183 / 696 cases (26 %) · ssm · mel_mskimpact_2020 · largest of 9 cohorts | — | — | Cutaneous Melanoma | 9 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZFHX4 122 / 469 cases (26 %) · ssm · skcm_tcga_gdc · largest of 7 cohorts | — | — | Cutaneous Melanoma | 7 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HECW1 76 / 293 cases (26 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RPTN 20 / 78 cases (26 %) · ssm · skcm_broad_brafresist_2012 | — | — | Cutaneous Melanoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SCAF11 20 / 78 cases (26 %) · ssm · skcm_broad_brafresist_2012 | — | — | Cutaneous Melanoma | 1 | Observed | cbioportal | graph → |